Public-Servant Complaints: Section 202 Inquiry Not Mandatory; Limitation Runs from Identification of Offender under Section 469(1)(c)

1) Introduction

The State of Kerala v. M/s. Panacea Biotec Ltd. (Supreme Court of India, 26-02-2026) consolidates three criminal appeals arising from prosecutions under the Drugs & Cosmetics Act, 1940 (“Act”)—one relating to alleged “misbranding” of a vaccine and another concerning a medical device allegedly “not of standard quality.” The common procedural controversy was whether the Magistrate was bound to conduct an inquiry/investigation under Section 202(1) of the Code of Criminal Procedure, 1973 (“Code”) before issuing process when the accused resided beyond territorial jurisdiction, even though the complaint was filed by a statutory Drugs Inspector (a public servant).

A second major issue in the vaccine prosecution concerned limitation for taking cognizance under Sections 468–469 of the Code: specifically, whether time began from the date the discrepancy was first reported or from the date the “identity of the offender” became known after official verification.

Parties and proceedings

  • Appellants: State of Kerala and Drugs Inspectors (statutory Inspectors under the Act).
  • Respondents/Accused: Corporate manufacturers/distributors and directors/managing personnel.
  • High Court (Kerala): Quashed complaints primarily for non-compliance with Section 202(1) and (in one matter) for perceived deficiency under Section 34 of the Act.
  • Supreme Court: Set aside the quashing orders and restored prosecutions, holding that public-servant complaints stand on a different footing when Section 202 is read harmoniously with Section 200 of the Code.

2) Summary of the Judgment

A) Vaccine “misbranding” prosecution (Thrissur)

  • The Supreme Court held that limitation was not a bar because the case attracted Section 469(1)(c) of the Code: the period commenced when the identity of the offenders became known to the competent authority after verification/inquiry, not from the earliest reported date of discrepancy.
  • On Section 202(1), the Court held that in an official written complaint by a public servant (Drugs Inspector), the Magistrate’s failure to conduct a Section 202 inquiry before issuing process to accused residing outside jurisdiction did not justify quashing, when Section 202 is construed harmoniously with the exemption in the proviso to Section 200 of the Code and the approach in Cheminova India Limited v. State of Punjab.
  • The High Court order quashing the complaint was set aside; summons order upheld; substitution directed for the deceased Managing Director by arraigning the person(s) in charge at the relevant time.

B) Accused’s cross-appeal (Thrissur)

  • Dismissed, as limitation was held not to bar cognizance on the Court’s computation under Sections 468–469.

C) “Not of standard quality” prosecution (Kozhikode)

  • The High Court’s quashing on Section 202(1) was set aside for the same reasons.
  • The High Court’s view that there was insufficient compliance with Section 34 of the Act (company/director liability) was held premature: whether directors were “in charge of” and “responsible to the company” is fact-intensive and should ordinarily be tested at trial.

3) Analysis

3.1 Precedents Cited

(i) Cheminova India Limited v. State of Punjab

The Court treated Cheminova India Limited v. State of Punjab as the controlling authority on the interface of Sections 200 and 202. It extracted and relied on the principle that the Code itself places a public servant complainant on a “different pedestal,” evident from the proviso to Section 200 (dispensing with examination on oath when the complaint is in writing by a public servant acting in discharge of official duties).

The present judgment extends that logic to reject a rigid application of the 2005 amendment to Section 202(1) (mandatory postponement/inquiry when accused resides beyond jurisdiction) in the context of official complaints. The Court expressly declined to accept factual distinctions urged by the accused (e.g., alleged absence of a Government Analyst’s report in the misbranding case), stating that the “clear enunciation” in Cheminova India Limited v. State of Punjab governed the issue.

Doctrinal effect of the reliance: The Supreme Court read Section 202’s protective purpose (avoiding harassment of innocent persons residing beyond jurisdiction) as substantially satisfied when the complaint is by a statutory public servant acting under a regulatory statute, especially given the Code’s own procedural relaxations for such complainants (Section 200 proviso; and, as noted in Cheminova, the evidentiary admissibility framework like Section 293 in appropriate cases).

(ii) Birla Corporation Limited v. Adventz Investments and Holdings Limited

The High Court had relied on Birla Corporation Limited v. Adventz Investments and Holdings Limited to insist on Section 202 compliance. The Supreme Court distinguished it on the decisive factual/legal axis that Birla Corporation Limited v. Adventz Investments and Holdings Limited involved a private complainant, not a public servant complaint made in discharge of official duty. Hence, it could not assist the accused against the statutory/official complaint paradigm.


3.2 Legal Reasoning

A) Limitation: Sections 468–469 and the trigger under Section 469(1)(c)

The Court framed limitation as one of two “twin questions” and held that, for offences punishable under Section 27(d) of the Act (imprisonment up to two years), the applicable limitation is three years (Section 468(2)(c) of the Code). The central move was the selection of the commencement rule:

  • The Court held that the case fit Section 469(1)(c): the limitation clock starts on the first day the identity of the offender becomes known to the aggrieved person or investigating police officer (whichever earlier), expressly recognizing that identity may emerge during “investigation into the offence.”
  • On facts, while the initial complaint was received in January 2006, the “identity of all the accused persons” was considered to have been before the competent authority only on 18.04.2006 after verification through the supply chain.
  • The formal complaint filed on 20.01.2009 and cognizance/summons on 29.01.2009 were within three years of 18.04.2006; thus, limitation did not bar cognizance.

Importantly, the Court treated the earlier High Court approach (computing from “21.10.2005”) as incorrect in principle because it invoked the wrong commencement clause (Section 469(1)(b) rather than Section 469(1)(c)).

B) Section 202(1) inquiry when accused resides beyond jurisdiction: harmonised reading with Section 200

The judgment acknowledges the 2005 amendment to Section 202(1), making inquiry/investigation mandatory where the accused resides beyond the Magistrate’s jurisdiction. However, the Court’s reasoning proceeds as follows:

  1. Section 200 proviso expressly dispenses with examination of the complainant and witnesses when the complaint is in writing by a public servant acting in discharge of official duties.
  2. In an official regulatory prosecution (here, under Section 32 of the Act), the complainant is not an ordinary private litigant but a statutory functionary.
  3. Therefore, Section 202 must be construed harmoniously with Section 200 in such cases; the Magistrate’s omission to conduct a Section 202 inquiry cannot be used to defeat the prosecution at the threshold, particularly where the complainant is a Drugs Inspector acting under statutory authority.
  4. The Court anchored this harmonised construction in the ratio of Cheminova India Limited v. State of Punjab, which recognizes the distinct procedural position of public-servant complaints.

C) Section 34 of the Act (company liability and directors): “premature” quashing

In the syringe matter, the High Court had quashed partly because it considered allegations against directors insufficient. The Supreme Court held this was premature because:

  • Section 34 liability turns on whether the director/manager was “in charge of” and “responsible to the company for the conduct of the business.”
  • These are questions of fact usually illuminated by evidence; the trial court is the proper forum to evaluate them “at the appropriate stage.”

3.3 Impact

(i) Regulatory prosecutions and procedural challenges under Section 202

The judgment significantly limits the use of Section 202(1) as a technical quashing tool against prosecutions initiated by statutory public servants under regulatory laws such as the Drugs & Cosmetics Act. Accused residing outside jurisdiction may find it harder to secure quashing solely on the ground that the Magistrate did not conduct a Section 202 inquiry, where the complaint is a written official complaint by a public servant in discharge of duty.

(ii) Limitation in supply-chain based offences

By locating the limitation trigger in Section 469(1)(c) where offender identity emerges through official verification, the Court strengthens prosecutorial latitude in offences involving multi-actor supply chains (manufacturers, distributors, retailers), where immediate identification is often not possible at the first reporting stage.

(iii) Corporate criminal liability in drugs/device prosecutions

The Court’s “prematurity” holding on Section 34 discourages early quashing of prosecutions against directors/managers where the complaint alleges their management role, pushing the contest on “in charge and responsible” to evidentiary stages (trial or appropriately framed discharge proceedings, as applicable).


4) Complex Concepts Simplified

  • “Taking cognizance”: the Magistrate’s formal act of applying mind to a complaint to proceed under criminal process; once cognizance is taken, the court may issue summons/process.
  • Section 468 limitation: bars cognizance after fixed periods based on maximum punishment; here, three years because Section 27(d) carries up to two years’ imprisonment.
  • Section 469(1)(c): the clock starts when the identity of the offender becomes known—crucial in cases where initial information does not reveal who in the chain is responsible.
  • Section 473 (extension): allows the court to take cognizance even after limitation if delay is explained or required in the interests of justice; here, the Court held the case was within limitation even without relying on Section 473.
  • Section 202(1) inquiry: a preliminary screening step, especially protective when accused lives outside the Magistrate’s territorial jurisdiction; the Court held that in public-servant written complaints, Section 202 must be read with Section 200’s exemption framework.
  • Section 200 proviso (public servant complaint): if a public servant files a written complaint in official capacity, the Magistrate need not examine the complainant/witnesses on oath at the threshold.
  • Misbranded drug: under Sections 17(b) and 17(c) of the Act, broadly refers to labelling/representation that is false, misleading, or not in the prescribed manner.
  • Section 34 (vicarious liability): makes persons who were in charge and responsible for the company’s business at the relevant time deemed guilty along with the company, subject to statutory conditions/defences.
  • Juristic entity: a company is treated as a “person” in law; proceedings can continue against the company even if an individual director/MD dies, subject to proper arraignment of responsible persons where required.

5) Conclusion

The Supreme Court’s decision establishes two practical rules of wide relevance in drugs/devices prosecutions: (1) for limitation, where offender identity emerges through official verification, the commencement is governed by Section 469(1)(c); and (2) for process issuance against out-of-jurisdiction accused, Section 202(1) is not to be applied in a vacuum—when the complaint is a written official complaint by a public servant, it must be read harmoniously with the Section 200 proviso, consistent with Cheminova India Limited v. State of Punjab. The Court also cautions against premature quashing on Section 34 director-liability questions, treating them as fact-intensive issues ordinarily suited for trial-stage determination.